Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:53 AM
Ignite Modification Date:
2025-12-25 @ 2:53 AM
NCT ID:
NCT01606033
Eligibility Criteria:
Inclusion Criteria:
* patient with solid tumor or recurrent hematologic cancer, treated by chemotherapy or targeted therapy evaluated every 2 or 3 cycles; except for clinical trials associating non drug treatment (radiotherapy, surgery...)
* subject to a 1st, 2nd or 3rd line of antitumor treatment
* a phase 2 open labeled study,
* a phase 2 or 3 blind randomised study,
* a phase 2 or 3 open randomised study,
* a standard treatment non participating to a clinical trial
* male or female patients ≥ 18 years of age
* karnovsky ≥ 70 % or OMS ≤ 2
* recovered from prior toxicities
* social security covered
* written informed consent given
Exclusion Criteria:
* psychiatric disorders, receiving psychotropic treatment
* physical or psychological issues
* forbidden to be included in this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01606033
Study Brief:
Protocol Section:
NCT01606033